GET THE APP

Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 1478 350008

Gerstenblith MR

Gerstenblith MR

 Department of Dermatology, University Hospitals Case Medical Center, Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Louisville, Kentucky, USA

Biography
Dr. Meg Gerstenblith, MD is a board certified dermatologist in Cleveland, Ohio. She is currently licensed to practice medicine in Ohio. She is affiliated with University Hospitals Case Medical Center and is an Assistant Professor at Case Western Reserve University School of Medicine. Dr. Meg Gerstenblith, MD is a board certified dermatologist in Cleveland, Ohio. She is currently licensed to practice medicine in Ohio. She is affiliated with University Hospitals Case Medical Center and is an Assistant Professor at Case Western Reserve University School of Medicine. Education & Training Johns Hopkins University Johns Hopkins University University of Pennsylvania Health System University of Pennsylvania Health System Johns Hopkins University School of Medicine Johns Hopkins University School of Medicine  Certifications & Licensure OH State Medical License OH State Medical License 2010 - 2017 American Board of Dermatology Dermatology Publications & Presentations PubMed Genetic vs Environmental Factors That Correlate With Rosacea: A Cohort-Based Survey of Twins. Aldrich, N.,Gerstenblith, M.,Fu, P.,Tuttle, M. S.,Varma, P.,Gotow, E.,Cooper, K. D.,Mann, M.,Popkin, D. L.; JAMA Dermatol. 2015 Aug 27. Multiple skin cancers in a patient within 1 year of allogeneic haematopoietic cell transplant for chronic lymphocytic leukaemia. Vyas, R.,Gotow, E. K.,DePry, J. L.,Lazarus, H. M.,Caimi, P. F.,Bordeaux, J. S.,Gerstenblith, M. R.; Clin. Exp. Dermatol.. 2015 Feb 17. Cutaneous histoplasmosis in renal transplant recipients. Sun, N. Z.,Augustine, J. J.,Gerstenblith, M. R.; Clin Transplant. 2014 Jun 26.
Research Interest

 Melanoma; Granuloma annulare; Immunotherapy; Ipilimumab; CTLA-4, Dermatology, Dermatological diseases.

Relevant Topics

Top
https://www.olimpbase.org/1937/